PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
A meta-analysis of eight trials showed a statistically significant reduction in the daily incidence of hot flushes (WMD -1.73 per day) in women receiving red clover compared to placebo [PMID:33920485]. Another meta-analysis found it effective for 3-4 months (MD=-1.34), though effects did not persist at 12 months [PMID:25074017]. However, other reviews note inconsistent evidence or a lack of clear demonstrable benefit [PMID:11528359, PMID:16645539].
A systematic review and meta-analysis of 12 RCTs demonstrated a significant decrease in total cholesterol (WMD -12.34 mg/dl) and low-density lipoprotein cholesterol (WMD -10.61 mg/dl) in peri- and postmenopausal women [PMID:30269660].
One study found a significant beneficial effect on arterial compliance [PMID:11528359].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 33920485 (2021) — Evaluation of Clinical Meaningfulness of Red Clover (Trifolium pratense L.) Extract to Relieve Hot Flushes and Menopausal Symptoms in Peri- and Post-Menopausal Women: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. · Nutrients
- 2.PMID: 29403626 (2017) — A review of effective herbal medicines in controlling menopausal symptoms. · Electronic physician
- 3.PMID: 16988360 (2006) — Red clover (Trifolium pratense). · Methods in molecular biology (Clifton, N.J.)
- 4.PMID: 40488850 (2025) — Formononetin: pharmacological properties and therapeutic potential. · Naunyn-Schmiedeberg's archives of pharmacology
- 5.PMID: 19134450 (2008)